Skip to main content

Table 3 Data collection schedule for the BETA Trial, Alberta, Canada

From: Study design and methods for the Breast Cancer and Exercise Trial in Alberta (BETA)

Assessments Time (months)
−1 to 0 baseline* 6 12 end of study 24 follow-up
Early screening     
Participant Eligibility Questionnaire x    
Questionnaires     
Baseline Health x    
Past Year Total Physical Activity Questionnaire x   x x
Canadian Diet History Questionnaire x   x x
Quality of Life x   x x
Predictors of Exercise Adherence x   x x
Psychological Stress x   x x
Satisfaction with Life, Happiness x   x x
Sedentary Behavior (SIT-Q) x   x x
Pittsburgh Sleep Quality Index x   x x
Participant Satisfaction with Exercise Intervention    x  
PAR Med-X 1 x    
Objective measurements     
Blood Sample x x x x
Submaximal Fitness Test x   x x
Anthropometry (height, weight, waist/hip circumference) x   x x
Accelerometry x 2 x x x
CT Scan3 x   x x
DXA Scan4 x   x x
  1. *All baseline measurements and questionnaires were completed prior to randomization. The exercise intervention began at baseline (time 0).
  2. 1PAR Med-X: Physical Activity Readiness Medical Examination.
  3. 2Step count data were retrieved from the accelerometer devices to assess study eligibility for any participant with a VO2max determined to be between 34.6 and 37.0 mL/kg/min.
  4. 3CT Scan: Computed Tomography Scan.
  5. 4DXA Scan: Dual Energy X-Ray Absorptiometry Scan.